Embody vs Push Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Embody
Best for lowest first-month entry pricing on compounded GLP-1sStarting at $99/mo
Push Health
Best for brand-name GLP-1 distribution via large pharmacy network (pending verification)Starting at $950/mo
Side-by-Side Comparison
| Feature | Embody | Push Health |
|---|---|---|
| Overall Score | ✓8.5/10 | 7.1/10 |
| Starting Price | ✓$99/mo | $950/mo |
| Editorial Rating | ✓4.3 ★ /5 | 3.6 ★ /5 |
| Features | ✓6 features | 5 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Embody
Pros
- ✓Lowest first-month entry pricing in the compounded segment ($99 first month for semaglutide, $149 for tirzepatide injection)
- ✓Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
- ✓Available in all 50 states with no insurance friction
- ✓24/7 unlimited clinician messaging and dose-adjustment support included
- ✓Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine
Cons
- ✗Refill pricing jumps to $299/month after the first month — initial $99/$149 is an intro rate, not the ongoing cost
- ✗Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
- ✗Pharmacy partners not publicly named — compounding source transparency is limited
- ✗Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate
Push Health
Pros
- ✓Brand-name-only GLP-1 distribution (Ozempic, Zepbound, Mounjaro)
- ✓55,000+ pharmacy network per competitor sources
- ✓LegitScript certified per competitor sources
- ✓Listed in both competitor directories
Cons
- ✗Brand-name-only — no compounded option
- ✗Stub entry — exact pricing, insurance coordination, and clinician workflow need YMYL verification
- ✗Confidence LOW until verified
Our Verdict
Embody edges out Push Health with a higher overall score of 8.5/10 and is particularly strong for lowest first-month entry pricing on compounded GLP-1s. Push Health remains a solid alternative, especially if you're looking for brand-name GLP-1 distribution via large pharmacy network (pending verification).
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.